Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Eyenovia Inc (NQ: EYEN )

0.1051 +0.0127 (+13.74%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Eyenovia Inc

< Previous 1 2 3 4 Next >
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
EYEN Stock Earnings: Eyenovia Misses EPS, Misses Revenue for Q4 2023
EYEN stock results show that Eyenovia missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023. 
Via InvestorPlace
Recap: Eyenovia Q4 Earnings
Via Benzinga
Earnings Scheduled For March 18, 2024
Companies Reporting Before The Bell • Niu Techs (NASDAQ:NIU) is expected to report earnings for its fourth quarter. 
Via Benzinga
Earnings Preview For Eyenovia
Via Benzinga
Earnings Preview: Eyenovia
Via Benzinga
NASDAQ:EYEN Investor Notice: Investigation over Potential Wrongdoing at Eyenovia, Inc.
San Diego, CA -- (SBWIRE) -- 10/11/2023 -- Certain directors of Eyenovia, Inc. are under investigation over potential breaches of fiduciary duties. 
Via SBWire
Earnings Preview For Eyenovia
Via Benzinga
Eyenovia Expands Its US Manufacturing Capabilities
Via ACCESSWIRE
Why SOPHiA GENETICS Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of SOPHiA GENETICS SA (NASDAQ: SOPH) fell sharply during Tuesday’s session after the company reported worse than expected fourth-quarter earnings and issued 2024 guidance. 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Recap: Eyenovia Q1 Earnings
Via Benzinga
A Preview Of Eyenovia's Earnings
Via Benzinga
Eyenovia Inc. (NASDAQ: EYEN) Records 52-Week High Tuesday Morning
Via Investor Brand Network
Preview: Eyenovia's Earnings
Via Benzinga
Beyond Cataract Surgery: Analyst Highlights Broader Market Potential For Eyenovia/Formosa's Steroid For Post-Eye Surgery Pain, Inflammation
FDA-approved clobetasol propionate ophthalmic suspension 0.05% (APP13007) by Formosa Pharma & AimMax. Breakthrough post-ocular surgery relief, first in 15 years. Eyenovia partnership. $1.3 billion... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
7 Promising Penny Stocks With the Potential to Defy Expectations
While market speculation can get extremely dangerous, those who understand the risks may like these high-potential penny stocks. 
Via InvestorPlace
Insiders Buying Eyenovia And 3 Other Stocks Under $2
The Dow Jones closed lower by around 80 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... 
Via Benzinga
Topics Stocks
Exposures US Equities
Earnings Scheduled For November 13, 2023
Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is expected to report earnings for its third quarter. • Dixie Gr (NASDAQ:DXYN) is estimated to report earnings for its third quarter. 
Via Benzinga
Eyenovia's Stock Is Soaring Today - Here's Why
William Blair initiated coverage on Eyenovia Inc (NASDAQ: EYEN), a biopharma company focused on developing therapies based on its Optejet device, which leverages a microdose array print (MAP)... 
Via Benzinga
Why Biophytis Shares Are Trading Higher By Over 12%: Here Are 20 Stocks Moving Premarket
Gainers 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
It's time to dive into the biggest pre-market stock movers as we start the trading week on Monday with the hottest coverage! 
Via InvestorPlace
Porch Group And 2 Other Stocks Under $3 Insiders Are Buying
The Dow Jones closed lower by over 100 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... 
Via Benzinga
Topics Stocks
Exposures US Equities
Glancy Prongay & Murray LLP Announces Investigation of Eyenovia, Inc. (EYEN)
From Glancy Prongay & Murray LLP
Via Business Wire
Eyenovia, Inc. (NASDAQ:EYEN) Investor Notice: Investigation over Possible Securities Laws Violations
San Diego, CA -- (SBWIRE) -- 05/24/2023 -- An investigation was announced for investors of Eyenovia, Inc. (NASDAQ:EYEN) shares over potential securities laws violations by Eyenovia, Inc. 
Via SBWire
Eyenovia Shares Dip Despite FDA Approving Its First Product
The FDA approved Eyenovia Inc's (NASDAQ: EYEN) Mydcombi (tropicamide and phenylephrine hydrochloride ophthalmic spray) 1%/2.5% for inducing mydriasis for diagnostic procedures and in conditions where... 
Via Benzinga
Glancy Prongay & Murray LLP Announces Investigation of Eyenovia, Inc. (EYEN)
From Glancy Prongay & Murray LLP
Via Business Wire
Top 5 Health Care Stocks That May Fall Off A Cliff This Quarter
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies. 
Via Benzinga
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.